U.S. Markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.60+0.08 (+0.64%)
At close: 4:00PM EST

12.75 +0.15 (1.19%)
After hours: 7:59PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.18
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 333.79
52 Week Low 32.28
50-Day Moving Average 311.06
200-Day Moving Average 315.22

Share Statistics

Avg Vol (3 month) 316.5M
Avg Vol (10 day) 315.99M
Shares Outstanding 5169.41M
Float 166.04M
% Held by Insiders 12.17%
% Held by Institutions 136.76%
Shares Short (Nov 12, 2020) 459.08M
Short Ratio (Nov 12, 2020) 46.84
Short % of Float (Nov 12, 2020) 435.59%
Short % of Shares Outstanding (Nov 12, 2020) 434.88%
Shares Short (prior month Oct 14, 2020) 455.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-5,841.53%

Management Effectiveness

Return on Assets (ttm)-26.14%
Return on Equity (ttm)-100.68%

Income Statement

Revenue (ttm)2.11M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-72.80%
Gross Profit (ttm)-82.01M
EBITDA -119.41M
Net Income Avi to Common (ttm)-179.73M
Diluted EPS (ttm)-1.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)337.24M
Total Cash Per Share (mrq)1.99
Total Debt (mrq)74.62M
Total Debt/Equity (mrq)23.03
Current Ratio (mrq)9.14
Book Value Per Share (mrq)1.93

Cash Flow Statement

Operating Cash Flow (ttm)-140.5M
Levered Free Cash Flow (ttm)-78.88M